Joint Formulary & PAD

Mexiletine hydrochloride - Myotonia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Capsules
Associated Icons :
BNF SPC
NHSE
NICE
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Mexiletine hydrochloride
Indication :
Myotonia
Group Name :
Keywords :
Myotonia in non-dystrophic myotonic disorders, sodium channel blockers
Brand Names Include :
Namuscla
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Mexiletine hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Myotonia.

  • No records returned.

Committee Recommendations (1)

This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Treatment should remain with the specialist (RED) hospital only drug.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.